I have held 5 aussie biotech stocks (ado, anp, bta, neu and pyc) during the past 5 years and have seen almost weekly speculation on each of them that a t/o was on the cards.
(It's a pity we can't bottle all the energy devoted to this topic, we probably wouldn't have needed so many wind-farms around the country).
The only one you could argue that eventuated was the reverse t/o by bta of nabi (not a raging success up until now).
Is there a recent history of biotech t/o's that I'm not aware of?
crunch these numbers, page-27
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
